Whitney Arthur
Family · Lenexa, KSNPI 1255116513
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 30.0% of the total. 2025 is the largest year on record at $684, 3.1 times the $218 reported in 2023.
Across 67 payments — averaging $21.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$429
- Lilly USA, LLC$186
- Ironshore Pharmaceuticals Inc.$132
- AstraZeneca$125
- Kowa Pharmaceuticals America, Inc.$122
- Boston Scientific$51
- plus $387 from 15 others
What the payments were for
- Food & beverage$1,433100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 12 | $429 |
| Lilly USA, LLC | 5 | $186 |
| Ironshore Pharmaceuticals Inc. | 8 | $132 |
| AstraZeneca | 8 | $125 |
| Kowa Pharmaceuticals America, Inc. | 8 | $122 |
| Boston Scientific | 3 | $51 |
| Shield Therapeutics Inc | 3 | $43 |
| Amgen | 2 | $38 |
| Ardelyx, Inc. | 2 | $36 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Axsome Therapeutics, Inc. | 2 | $31 |
| Boehringer Ingelheim | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 2 | $29 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Novo Nordisk | 1 | $18 |
| Merck | 1 | $17 |
| Dexcom, Inc. | 1 | $17 |
| Organon | 1 | $15 |
| Bayer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,433 in reported general payments places this provider in the 80th percentile of 1,579 family providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 46 | $288 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 24 | $240 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 30 | $196 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $190 |
| Mupirocin | 18 | $146 |
| Doxycycline Hyclate | 21 | $145 |
| Ciprofloxacin Hcl | 21 | $102 |
| Azithromycin | 32 | $96 |
| Cephalexin | 17 | $77 |
| Prednisone | 26 | $31 |
| Amoxicillin | 13 | $25 |
Paid to pharmacies, not to this prescriber.
Other family in Lenexa
- Jennifer AndersonLenexa$9K
- Anna CattauLenexa$7K
- Zohra HussainiKansas City$329K
- Jennifer ChesterOverland Park$327K
- Amanda CaldwellLeawood$203K
- Kayla del RioWichita$147K
- Kelli RiceWichita$114K
- Tatum TolandTopeka$108K
- Mary GonzalesWichita$87K
- Erin FeitzOverland Park$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.